5 July 2025 · 23 min

Generative AI for Health: A WEF Look at the Future of Personalized Care

The World Economic Forum ranks Generative AI for Health as one of the Top 10 Emerging Technologies of 2024. But what does that really mean for hospitals, clinicians, and patient outcomes?

In this episode, we unpack the WEF insights and explore how GenAI is reshaping diagnostics, drug discovery, and personalized care—along with the regulatory and ethical challenges that still loom large.

#AIinMedicine #DigitalHealth #WEF #HealthcareInnovation
@AI in Healthcare @Coalition for Health AI (CHAI) @American Board of Artificial Intelligence in Medicine (ABAIM)

Your company here. This podcast is looking for its first sponsors: reach clinicians, health-system leaders and medtech and pharma teams following AI in medicine. Sponsorship options and rates →

Transcript

Automated transcript of the audio; it may contain errors.

Host 1: Okay, so what if you could have like a crystal ball for the future of technology,

Host 2: Mhm.

Host 1: showing you the innovations that are quite literally at a turning point right now, breakthroughs, you know, poised to transform our world, maybe sooner than we think.

Host 2: Yeah.

Host 1: Today, our deep dive is going to give you a shortcut, basically, to understanding these advancements without all the usual information overload.

Host 2: And what's really fascinating here, I think, is how our source material, this is the World Economic Forum's Top 10 Emerging Technologies of 2025 report, uh developed with Frontiers, it it moves beyond just, you know, listing things.

Host 1: Right.

Host 2: Actually helps us understand their strategic outlook, their potential for well, for societal transformation. It shines a spotlight on tech moving from the lab to the real world.

Host 1: Exactly why we're excited about this one. Our mission today is really to give you that well-informed advantage,

Host 2: Mhm.

Host 1: highlighting what's most important, why it matters so you're sort of ready for what's coming.

Host 2: Mhm.

Host 1: And the report groups these into some really interesting patterns.

Host 2: It does.

Host 1: So we'll explore them through those lenses, maybe starting with uh how we power our world.

Host 2: Sounds good.

Host 1: Okay, let's jump right into something, well, truly mind-bending.

Host 2: Okay.

Host 1: Imagine a world where the very structure of things around us also powers them.

Host 2: Ah, yeah.

Host 1: Like energy and materials becoming one.

Host 2: That's the essence of structural battery composites, SBCs for short.

Host 1: SBCs.

Host 2: Yeah, picture materials like carbon fiber.

Host 1: Mhm.

Host 2: It's not just forming, say, a car's body panel, it's also storing energy directly in that structure.

Host 1: Wow.

Host 2: So unlike traditional batteries, you know, heavy, bulky add-ons, SBCs are rigid. They're integral components. You can even 3D print them, optimize them for surface area and structural strength.

Host 1: So wait, if the car body is the battery, that sounds like something out of sci-fi.

Host 2: Heh, yeah.

Host 1: Is this just a concept, or are companies act- I think I read Airbus is looking into this for planes?

Host 2: It's very much in active development. Airbus is, yeah, they're experimenting with these.

Host 1: Okay.

Host 2: But the real breakthrough here isn't just, like, lighter vehicles, it's a fundamental reimagining of how energy is stored.

Host 1: Right.

Host 2: It's moving from an added component to this integral, sort of massless part of the structure itself.

Host 1: Massless energy.

Host 2: The impact could be huge. Economically, you cut manufacturing costs, you reduce weight,

Host 1: Yeah. Which means better efficiency.

Host 2: Yeah, exactly. Like a 10% weight reduction in a vehicle, that could mean 6-8% better fuel efficiency.

Host 1: Wow.

Host 2: And for EVs, maybe a 70% increase in range. Environmentally, obviously, energy-efficient designs, maybe easier recycling, too.

Host 1: But there must be challenges.

Host 2: Oh, absolutely. Achieving um high enough energy density, making sure they're stable long-term, safety, cost-effectiveness at scale, those are big hurdles.

Host 1: Yeah.

Host 2: And of course the carbon footprint of making materials like carbon fiber in the first place, that needs work too.

Host 1: Okay, so from integrated power, let's switch gears.

Host 2: Yeah.

Host 1: Harnessing the power of water itself, something called salt power.

Host 2: Right. Osmotic power systems, basically generating clean, renewable, and maybe most importantly, steady energy by using that natural difference in salt content between two water sources. Think fresh river water meeting salty ocean water.

Host 1: Ah, okay. So unlike solar or wind, which fluctuate.

Host 2: Exactly. This source is constant. Now there are two main designs emerging. One's called pressure-retarded osmosis, or PRO.

Host 1: PRO.

Host 2: And the other is reverse electrodialysis, RED, which actually generates electricity directly from that salinity difference.

Host 1: That's quite a leap. Is this just theoretical stuff or are there actual projects running?

Host 2: No, we're definitely seeing real-world progress. Sweetch Energy's Osmorun 1, they started installations last year,

Host 1: In France, right?

Host 2: Yep, and in Denmark, SaltPower is already generating electricity using geothermal salt solutions.

Host 1: Geothermal salt, interesting.

Host 2: Even Japan's Megaton Water System is getting energy from the really salty waste that comes out of desalination plants.

Host 1: Huh, so finding energy in waste streams, too.

Host 2: And what's even cooler, maybe, is the potential beyond just energy.

Host 1: Oh?

Host 2: Techniques like RED, they can also purify water and recover valuable stuff like lithium, nitrogen, even CO2 from the water.

Host 1: Wow, okay. So multiple benefits.

Host 2: Potentially huge scale, too. These systems could generate something like 5,177 terawatt-hours a year.

Host 1: That sounds like a lot. How much is that?

Host 2: Nearly a fifth of global electricity needs.

Host 1: A fifth? Seriously?

Host 2: Yeah, it could totally transform water management. Now older systems had issues, you know, membranes getting clogged, high costs,

Host 1: Yeah.

Host 2: but recent advances in materials, new designs, they're rapidly improving performance and making it more viable.

Host 1: Okay, sticking with steady energy,

Host 2: Yeah.

Host 1: let's talk nuclear. You might think you know nuclear power, but this next-gen stuff, it seems poised to redefine things. It's definitely not your grandparents' reactor.

Host 2: Exactly. And the drivers for advanced nuclear technologies are clearer than ever.

Host 1: Like what?

Host 2: Well, rapidly increasing energy demand, for one. Think electric cars, AI data centers,

Host 1: Right, they need tons of power.

Host 2: Tons. And couple that with a huge push for decarbonization. So we're seeing advancements in, uh, Generation III+ reactors. They build on proven designs, but add better passive safety features. And then there's Generation IV, that's the real next-gen leap. They use different coolants: molten metals, gases,

Host 1: Instead of water?

Host 2: Right. They operate at higher temperatures, lower pressures, that simplifies the designs, makes them inherently safer,

Host 1: Yeah.

Host 2: potentially more efficient, too.

Host 1: And crucially, we're seeing the rise of small modular reactors, SMRs.

Host 2: Oh, yes. Yes.

Host 1: These are factory-built, smaller units, like a third the capacity of the big, traditional plants.

Host 2: Typically, yeah.

Host 1: That sounds like a total game-changer for decentralized power. Could they really cut those huge costs and long construction times we associate with nuclear?

Host 2: They absolutely could. That's precisely why they're so attractive right now.

Host 1: Okay.

Host 2: Global investment is really picking up. South Korea gets a third of its power from nuclear already. The UAE is investing like $163 billion by 2050.

Host 1: Uh-huh.

Host 2: Russia and China, they already have operational SMRs,

Host 1: Already running?

Host 2: Yep, and Western countries are moving fast on designs and regulations. And then there's the sort of, um, holy grail: nuclear fusion.

Host 1: Fusion, right. Limitless clean energy, eventually.

Host 2: Eventu- Well, there's actually pretty high confidence it could mature within maybe one to two decades.

Host 1: Really? That soon?

Host 2: That's the projection. Strategically, SMRs could bring zero-carbon power to remote places. Gas-cooled reactors could help decarbonize heavy industry, that's like 15% of global CO2.

Host 1: Mmm.

Host 2: And even produce hydrogen fuel. But challenges remain, big ones. High upfront capital costs, still. Supply chain issues for specialized materials, you know, radiation-resistant alloys,

Host 1: Okay.

Host 2: And actually, a bit of a worrying trend, a decline in nuclear engineering talent, like a 25% drop in grads between 2012 and 2022.

Host 1: Oof, that's not good. Need the people.

Host 2: Definitely need the people. And then the usuals: building public trust, making sure cybersecurity is rock solid.

Host 1: Right. Huge infrastructure projects always have those hurdles.

Host 2: Yeah.

Host 1: Okay, let's shift gears. From powering the planet to something, well, much more personal: how biology is being engineered to maybe revolutionize our health.

Host 2: Mhm.

Host 1: Makes you think, could our own bodies become the ultimate pharmacy?

Host 2: Well, that brings us to engineered living therapeutics.

Host 1: Okay.

Host 2: These are basically advanced probiotic systems. Think microbes, cells, maybe fungi, genetically engineered

Host 1: Engineered how?

Host 2: to produce therapeutic stuff like drugs directly inside the patient's body.

Host 1: Inside the body.

Host 2: Yeah, and what's really revolutionary potentially is they can be controlled precisely, maybe by triggers the patient manages or even responding automatically to specific disease signals. Targeted, safe activation.

Host 1: That is incredible. So what does this mean for you, the the listener? We're talking about drugs being made inside your own body on demand,

Host 2: Potentially, yeah.

Host 1: avoiding constant injections maybe, and slashing production costs. How big are those savings?

Host 2: They could be pretty significant. The traditional drug-making process, all the purification, processing, about 70% of the cost is in those downstream steps.

Host 1: Right.

Host 2: Making the drug right in the body cuts a lot of that out. And we're already seeing companies making real strides here.

Host 1: Examples?

Host 2: Chariot Bioscience, they're looking at microbially platforms that release the drug after just a single dose.

Host 1: Single dose.

Host 2: Aurealis Therapeutics is in phase two trials for diabetic foot ulcers using a modified probiotic bacteria. NEC is even using weakened Salmonella to get the immune system to fight cancer cells.

Host 1: Salmonella? Okay.

Host 2: Yeah.

Host 1: But safety must be paramount here.

Host 2: Absolutely, that's the primary hurdle: preventing, you know, unintended gene transfer, avoiding unwanted immune responses,

Host 1: Yeah.

Host 2: and of course new regulatory frameworks are needed to really evaluate how safe and effective these are before they hit the market.

Host 1: Makes sense.

Host 2: Uh-huh.

Host 1: Okay, next up, a familiar class of drugs, but with a really surprising new application. It's like finding a whole new use for, I don't know, duct tape or something.

Host 2: Oh yeah, yeah, maybe. We're talking about GLP-1s for neurodegenerative diseases.

Host 1: GLP-1s, those are the diabetes and weight loss drugs everyone's talking about, right? Ozempic, Wegovy.

Host 2: Exactly those, GLP-1 receptor agonists. But surprisingly, they're now being seriously explored for treating conditions like Alzheimer's and Parkinson's.

Host 1: Alzheimer's and Parkinson's? How?

Host 2: Well, early research suggests they have some remarkable neuroprotective properties.

Host 1: Neuroprotective, meaning they protect brain cells.

Host 2: Basically, yeah. What's fascinating is how they seem to work. They can cross the blood-brain barrier,

Host 1: Which is notoriously hard to do.

Host 2: very hard. And once there, they seem to reduce inflammation, help clear out those toxic proteins linked to these diseases,

Host 1: Like amyloid plaques.

Host 2: Exactly. And they might even enhance brain cell longevity, help with energy regulation in the brain, potentially improving cognition and motor function.

Host 1: If, I mean, if these prove effective, the societal impact is just massive.

Host 2: Oh, absolutely.

Host 1: Over 55 million people worldwide live with dementia, and the GLP-1 market itself is already huge, projected for what, $55 billion by 2031?

Host 2: Yeah, $55.7 billion.

Host 1: So what could this do for the cost of care, both emotional and financial?

Host 2: It could be truly transformative. It could dramatically reduce those burdens, offer real hope where, frankly, there hasn't been much.

Host 1: But it's still early days.

Host 2: Definitely. We need rigorous clinical trials to confirm they actually work long-term for these conditions. And there are challenges: getting regulatory approval, obviously, the current high cost of these drugs that could limit access,

Host 1: Yeah, they're expensive.

Host 2: and you need careful safety monitoring, especially potential weight loss in patients who might already be frail. That needs watching.

Host 1: Right, very important considerations. Okay, so from health, let's zoom back out. How our fundamental industrial processes are being completely reimagined for, you know, a more sustainable, more efficient future.

Host 2: Mhm.

Host 1: Imagine industry becoming as smart and maybe proactive as our own bodies seem to be getting.

Host 2: Well, this next segment starts with autonomous biochemical sensing.

Host 1: Okay, break it down.

Host 2: These are basically self-operating, continuous analytical devices.

Host 1: Continuous.

Host 2: Yeah, designed to detect and measure specific biochemical things. Could be disease markers for personalized health, or environmental pollutants in soil or water.

Host 1: And they do this on their own?

Host 2: Right. They use wireless communication, they often have self-sustaining power sources, so they can monitor continuously in real time, no human intervention needed.

Host 1: That's a huge shift. So we're not talking about a single-use COVID test anymore.

Host 2: No.

Host 1: This is continuous real-time data, like the wearable glucose monitor that talks to your phone.

Host 2: Mhm.

Host 1: That's really just the beginning.

Host 2: Precisely. That's a great example. And big companies - Abbott, Roche, DuPont - they're investing heavily here.

Host 1: What are some emerging uses?

Host 2: We're seeing wearable sensors being developed for inflammation, continuous monitoring of female hormones, com- company called Prosperida Health is working on that,

Host 1: Interesting.

Host 2: and even microbial whole-cell biosensors, using engineered microbes to actually signal when they detect something specific.

Host 1: Using microbes as the sensor, okay. What's the overall impact?

Host 2: It could really transform individualized health management, improve food safety. Imagine detecting toxins maybe a thousand times more sensitively in under a minute.

Host 1: Wow.

Host 2: And enable proactive environmental protection instead of just reacting after the fact.

Host 1: But there must be downsides: lifespan?

Host 2: Yeah, current sensors often have short lifespans, need regular replacement, that's a challenge.

Host 1: And the microbe ones?

Host 2: The genetically engineered microbial sensors, they face unique regulatory hurdles, because, you know, what happens if they get released into the environment? That's a key focus for development.

Host 1: Right, makes sense. Okay, next, a really essential process for our food supply is apparently getting a green makeover.

Host 2: Mhm.

Host 1: Sounds like changing something fundamental we often just take for granted.

Host 2: We're talking about green nitrogen fixation.

Host 1: Nitrogen fixation.

Host 2: Oh, yeah.

Host 1: Making ammonia for fertilizer.

Host 2: Exactly. It's a huge market: $200 billion in the US alone. Produces the ammonia for fertilizer that supports like half the world's food production.

Host 1: Half, wow.

Host 2: But the traditional way of doing it, the Haber-Bosch process, it's very energy-intensive, uses about 2% of global energy consumption,

Host 1: 2% just for fertilizer.

Host 2: Yeah, and creates significant CO2 emissions because it needs high temperatures, high pressures, and relies heavily on natural gas.

Host 1: Okay, so green nitrogen fixation aims to fix that.

Host 2: Aims to vastly lower that carbon footprint, yes.

Host 1: How? What are the new approaches?

Host 2: Well, using bio-based methods, engineered bacteria, enzymes, bio-inspired systems that mimic how those enzymes work, and electrochemical technologies.

Host 1: Like using electricity.

Host 2: Exactly. Things like lithium-mediated processes. The big goal is to make ammonia using only air, water, and renewable electricity.

Host 1: Air, water, and green power.

Host 2: Which could allow for decentralized production. Imagine making ammonia locally using local solar or wind power.

Host 1: Ah, cutting transport costs and emissions.

Host 2: Precisely. And there's potential beyond fertilizer, too. Ammonia is being looked at seriously as a carbon-free fuel for ships.

Host 1: Marine fuel?

Host 2: Yeah, could maybe power 30% of global marine fuel by 2050.

Host 1: Okay. Are these green methods viable yet?

Host 2: Well, ammonia plants based on green hydrogen are proving viable, but the commercial viability of some newer methods, like the lithium chemistry or the biology-based ones, that's still being established.

Host 1: And other challenges?

Host 2: You still have to consider ammonia's toxicity and potential PM2.5 emissions. Plus, if you rely on lithium processes, lithium is a critical mineral, demand is skyrocketing, that's a factor.

Host 1: Right, dependency on critical minerals again.

Host 2: Mhm.

Host 1: Okay, and for efficiency, we're going really small now, down to the nanoscale, with tiny catalysts that mimic nature.

Host 2: It's like having microscopic, super-efficient little helpers, yeah.

Host 1: What are they called?

Host 2: Nanozymes. These are lab-produced nanomaterials that basically act like natural enzymes.

Host 1: But better?

Host 2: Well, different advantages. They tend to have increased stability, lower production costs, and they're simpler to synthesize than isolating natural enzymes.

Host 1: Okay.

Host 2: And crucially, they can often function in diverse, harsh environments: high temps, weird pH, where natural enzymes would just break down.

Host 1: So more robust. Where are they being used?

Host 2: There's significant pharma investment happening, promising clinical trials in cancer, neurodegenerative diseases, they seem to help mitigate oxidative stress, reduce inflammation.

Host 1: Help again, any companies?

Host 2: Level Nine is looking at them for industrial biomanufacturing. Nanozyme Inc is working on targeted disease treatment.

Host 1: It's incredible, the scale we're talking. And it's not just health, right? The market is projected to boom from like $5 billion to nearly $58 billion by 2034.

Host 2: That's the projection.

Host 1: What else could they do? Water purification, food safety?

Host 2: Absolutely. Their potential in water purification, rapid detection of food contaminants, making industrial catalysis more efficient, maybe offering greener alternatives to traditional metal catalysts, it's broad.

Host 1: What are the catches?

Host 2: Improving their selectivity, making sure they only catalyze the reaction you want, and boosting catalytic efficiency to really match or beat natural enzymes, that's ongoing work.

Host 1: And safety, especially if they're used in the body.

Host 2: Exactly. Biocompatibility, long-term safety, those are critical as they move into medical applications. And the regulatory framework for nano products is still kind of evolving, that impacts commercialization.

Host 1: Okay, final stretch.

Host 2: Yeah.

Host 1: In our super digital, super connected world,

Host 2: Uh-huh.

Host 1: how do we build trust? These last technologies seem to tackle that head-on.

Host 2: Yeah, creating new foundations for trust in these complex systems.

Host 1: Starting with?

Host 2: The first one is collaborative sensing.

Host 1: Okay. Sensing we know, but collaborative?

Host 2: It involves connecting all those ubiquitous sensing devices we already have in our homes, cars, workplaces,

Host 1: Everything with a sensor.

Host 2: pretty much, and then integrating them with AI systems to generate much richer, enhanced insights. It allows individual sensors to sort of pool their data, collectively improve their capabilities, get a more complete picture.

Host 1: That sounds incredibly powerful. Give me an example.

Host 2: Okay, so imagine an autonomous vehicle. It doesn't just rely on its own sensors,

Host 1: For lidars, cameras.

Host 2: Right. But it also knows a speeding car is approaching an intersection way ahead because it got a signal from connected sensors on a traffic light maybe hundreds of yards away.

Host 1: Ah, okay. That's vehicle-to-everything, V2X.

Host 2: That's V2X in action, exactly. The US FCC actually just adopted the 5.9 GHz band specifically for cellular V2X to enable this kind of thing.

Host 1: So it's happening. What else besides safer cars?

Host 2: Oh, loads. Improving city traffic flow with dynamic traffic lights, large-scale autonomous mapping in mines, analyzing storm systems by combining weather station data, coordinating drone swarms, precision agriculture.

Host 1: Wow, okay. The impact seems huge: safety, efficiency.

Host 2: Definitely. V2X could reduce crashes by, studies suggest, 59-77%. Truck platooning - trucks driving closely together using V2X - could save 5-10% on fuel.

Host 1: Significant.

Host 2: And 5G helps here, too, improving location accuracy from maybe over a meter down to 0.1 m with super high reliability.

Host 1: 0.1 m, that's tiny.

Host 2: Yeah. This stuff really could reshape cities, supply chains, emergency response, but

Host 1: challenges.

Host 2: Always challenges.

Host 1: Like what?

Host 2: Power and connectivity for all those sensors, especially remote ones, big challenge. Data sharing security, privacy policies, huge deal. We need common data standards so different systems can talk to each other.

Host 1: Interoperability.

Host 2: Right. And just expanding 5G infrastructure, it currently only reaches about 55% of the global population, still got a way to go.

Host 1: Okay. Last one. In this era of AI generating text, images, video, it's getting really hard to tell what's real sometimes.

Host 2: Tell me about it.

Host 1: How do we know what we're consuming is authentic? This next tech sounds like it's about embedding invisible markers.

Host 2: That's generative watermarking. It's about embedding these, well, invisible signals or markers into AI-generated content.

Host 1: Text, images, audio, video, all of it?

Host 2: All of it. The goal is to verify authenticity, trace the origin.

Host 1: Why is that so important?

Host 2: Well, combating misinformation, obviously. Protecting intellectual property, fighting academic dishonesty like AI-written essays, basically promoting trust in digital content, which feels like it's eroding.

Host 1: Yeah, it does. How does it work? Is it like a visible watermark?

Host 2: No, usually invisible to us. For text, it might involve subtly substituting words here and there to create a unique pattern, like an AI-specific textual fingerprint.

Host 1: So the meaning stays the same, but the word choice has a hidden signal.

Host 2: Kind of like that. Google DeepMind's SynthID does something along those lines. For images or video, it could be tiny, imperceptible changes to pixels or hidden patterns only a machine can detect.

Host 1: Clever. Is industry adopting this?

Host 2: They are moving fast. Major AI players - OpenAI, Google, Meta - they all committed to developing watermarking back in 2023. Google actually open-sourced SynthID in 2024. Meta introduced something called VideoSeal. And we're seeing regulations emerge. China, the EU, California, are all looking at rules around content provenance.

Host 1: But can't people just remove the watermarks, or fake them?

Host 2: That's definitely a challenge. Simple edits like cropping an image or even just taking a screenshot could potentially disrupt detection.

Host 1: Hmm.

Host 2: And yeah, people will try to remove or forge watermarks. Plus, if not everyone adopts it, its effectiveness is weakened.

Host 1: Patchy adoption.

Host 2: Right. And there are ethical concerns, too. What if something is wrongly labeled as AI-generated, or vice versa? False positives or negatives could be a problem.

Host 1: True. What's the bigger picture here?

Host 2: Strategically, this could become a really critical piece of our digital trust infrastructure. It might even reshape legal and financial systems if watermarked content starts having real evidentiary value.

Host 1: Like proving authenticity in court.

Host 2: Potentially. Especially if you integrate it with something like blockchain for verifiable tamper-proof watermarks, that's a promising future direction.

Host 1: Okay, wow. So what does this all mean, wrapping up? We've covered a lot. We've taken this deep dive into innovations that are, as you said, literally at their turning point.

Host 2: Mhm.

Host 1: From how our buildings or cars might store energy, to how we verify what's real in this flood of digital content, the breadth, the depth, it's kind of astounding.

Host 2: Yeah. It really is. And if we connect this back to the bigger picture, I think these 10 technologies really showcase humanity's incredible capacity to adapt, to innovate, especially when facing complex challenges like climate change or disease.

Host 1: But it's not just about the tech itself, is it?

Host 2: No, absolutely not. These aren't just isolated breakthroughs, they're signals of much broader transformations coming down the line.

Host 1: Right.

Host 2: And realizing their full potential, that's going to require massive collaboration.

Host 1: Across sectors.

Host 2: Across science, government, business, society. Everyone needs to be part of the conversation to navigate these changes effectively and, hopefully, equitably.

Host 1: Which kind of leaves a big question for you, the listener, doesn't it?

Host 2: Yeah.

Host 1: As these technologies mature, as they move from the lab to our lives, how might they change your daily routine, your community, maybe even the global landscape in ways we can probably barely imagine today?

Host 2: That's the multibillion-dollar question, isn't it? Something to definitely keep thinking about.